Insights

Innovative Technology Newomics offers cutting-edge LC-MS platforms featuring award-winning multinozzle emitter technology, which provides unparalleled sensitivity and throughput, making it highly attractive for labs seeking advanced molecular analysis solutions.

Growing Product Portfolio Recent product launches such as the FSK-AM adjustable microflow splitter and UniESI sources for various mass spectrometers demonstrate Newomics's commitment to expanding and customizing its solutions for diverse high-performance LC-MS applications.

Strategic Collaborations Partnerships with industry leaders like Agilent Technologies and targeted programs for Bruker MS users indicate opportunities for cross-selling and expanding market reach to established mass spectrometry user bases.

Market Expansion Participation in prominent metabolomics conferences and industry events positions Newomics to attract new scientific collaborations and end-user adoption, boosting visibility among research institutions and biotech companies.

Financial and Growth Potential With a current revenue estimate of up to 10 million dollars and over 7 million dollars in funding, Newomics is positioned for scalable growth that presents opportunities for upselling existing product lines and introducing new innovative solutions to the market.

Newomics, Inc. Tech Stack

Newomics, Inc. uses 8 technology products and services including Microsoft 365, JSON-LD, jQuery Migrate, and more. Explore Newomics, Inc.'s tech stack below.

  • Microsoft 365
    Email
  • JSON-LD
    Javascript Frameworks
  • jQuery Migrate
    Javascript Libraries
  • Priority Hints
    Performance
  • WP Engine
    Platform As A Service
  • Plyr
    Video Players
  • Google Analytics
    Web Analytics
  • Gravity Forms
    Web Platform Extensions

Media & News

Newomics, Inc.'s Email Address Formats

Newomics, Inc. uses at least 1 format(s):
Newomics, Inc. Email FormatsExamplePercentage
Last@newomics.comDoe@newomics.com
29%
FLast@newomics.comJDoe@newomics.com
21%
Last@newomics.comDoe@newomics.com
29%
FLast@newomics.comJDoe@newomics.com
21%

Frequently Asked Questions

What is Newomics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Newomics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Newomics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Newomics, Inc.'s official website is newomics.com and has social profiles on LinkedInCrunchbase.

What is Newomics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Newomics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Newomics, Inc. have currently?

Minus sign iconPlus sign icon
As of December 2025, Newomics, Inc. has approximately 11 employees across 1 continents, including North America. Key team members include Vice President Operations: D. H.Co-Executive Director, Global Water Works: F. S.Sr. Mems Manufacturing Manager: H. W.. Explore Newomics, Inc.'s employee directory with LeadIQ.

What industry does Newomics, Inc. belong to?

Minus sign iconPlus sign icon
Newomics, Inc. operates in the Biotechnology Research industry.

What technology does Newomics, Inc. use?

Minus sign iconPlus sign icon
Newomics, Inc.'s tech stack includes Microsoft 365JSON-LDjQuery MigratePriority HintsWP EnginePlyrGoogle AnalyticsGravity Forms.

What is Newomics, Inc.'s email format?

Minus sign iconPlus sign icon
Newomics, Inc.'s email format typically follows the pattern of Last@newomics.com. Find more Newomics, Inc. email formats with LeadIQ.

How much funding has Newomics, Inc. raised to date?

Minus sign iconPlus sign icon
As of December 2025, Newomics, Inc. has raised $7.9M in funding. The last funding round occurred on Dec 01, 2020 for $7.9M.

Newomics, Inc.

Biotechnology ResearchCalifornia, United States11-50 Employees

Newomics is a biotech company that sells and develops innovative and integrative platforms for LC-MS. In particular, the award-winning multinozzle M3 emitter, with the MnESI ion source, enhances the ionization efficiency to achieve unprecedented sensitivity, throughput, and robustness.


Our proprietary technology is based on silicon-microfluidic-chip for liquid chromatography-mass spectrometry (LC-MS), and offers unprecedented robustness, sensitivity, specificity, and throughput for analyzing molecules from minute amounts of biospecimens such as blood and urine. 

Our core technologies are built upon the multinozzle emitter array (MEA) technology, invented from the Lawrence Berkeley National Laboratory (Berkeley Lab), which has won the 2012 R&D 100 award.

Section iconCompany Overview

Phone number
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconFunding & Financials

  • $7.9M

    Newomics, Inc. has raised a total of $7.9M of funding over 3 rounds. Their latest funding round was raised on Dec 01, 2020 in the amount of $7.9M.

  • $1M$10M

    Newomics, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $7.9M

    Newomics, Inc. has raised a total of $7.9M of funding over 3 rounds. Their latest funding round was raised on Dec 01, 2020 in the amount of $7.9M.

  • $1M$10M

    Newomics, Inc.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.